期刊
CURRENT HYPERTENSION REPORTS
卷 21, 期 11, 页码 -出版社
SPRINGER
DOI: 10.1007/s11906-019-0994-z
关键词
Biliverdin reductase; PPARalpha; Kidney; Hypertension; Metabolic syndrome
资金
- National Institutes of Health (NIH) [K01HL125445, R01DK121017]
- University of Toledo Medical Research Society [R01HL088421, P01HL051971]
- National Heart, Lung and Blood Institute [P20GM-104357]
- National Institute of General Medical Sciences
Purpose of Review To discuss recent advances indicating that bilirubin safeguards against cardiorenal and metabolic diseases. Recent Findings Several investigations from human patient populations and experimental animal models have shown that bilirubin improves cardiorenal and metabolic dysfunction. The latest studies found an entirely new function of bilirubin suggesting that it acts as a hormone signaling molecule capable of activating nuclear receptors for burning fat, which may explain several of its protective actions. Summary This review highlights the current findings (within the last 3 years) regarding cardiorenal and metabolic protective effects of bilirubin and the latest mechanism(s) that may be mediating these effects.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据